PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34479089-9	2021	Irisin treatment significantly alleviated ROS accumulation, autophagy disorder, NF-kappaB-Snail pathway activation as well as the phenotype of EndMT by targeting uncoupling protein 2 (UCP2).	irisin	0-6	uncoupling protein 2 (mitochondrial, proton carrier)	Mus musculus	162-182	
32934963-0	2020	Irisin Pretreatment Protects Kidneys against Acute Kidney Injury Induced by Ischemia/Reperfusion via Upregulating the Expression of Uncoupling Protein 2.	irisin	0-6	uncoupling protein 2 (mitochondrial, proton carrier)	Mus musculus	132-152	
32934963-8	2020	Irisin pretreatment ameliorated the cell apoptosis induced by H/R, while transfection of UCP2 siRNA significantly reduced the protective effect of irisin in cells after H/R.	irisin	147-153	uncoupling protein 2 (mitochondrial, proton carrier)	Mus musculus	89-93	
32934963-9	2020	In addition, AMPK signaling may be involved in irisin-mediated upregulation of UCP2 in a renal proximal tubular epithelial cell (PTEC) model.	irisin	47-53	uncoupling protein 2 (mitochondrial, proton carrier)	Mus musculus	79-83	
34479089-9	2021	Irisin treatment significantly alleviated ROS accumulation, autophagy disorder, NF-kappaB-Snail pathway activation as well as the phenotype of EndMT by targeting uncoupling protein 2 (UCP2).	irisin	0-6	uncoupling protein 2 (mitochondrial, proton carrier)	Mus musculus	184-188	
34479089-12	2021	Irisin treatment could partially reverse this phenomenon by regulating UCP2.	irisin	0-6	uncoupling protein 2 (mitochondrial, proton carrier)	Mus musculus	71-75